Significant Moves in Stock Market: Carlyle Group and Seadrill Rise, PG&E and Argenx Fall

Carlyle Group and WP Carey join S&P MidCap 400, while Springworks' tumor treatment gets regulatory approval.

• Carlyle Group Inc. and WP Carey Inc. are set to join the S&P MidCap 400 index.
• Seadrill Ltd. exceeded analysts' third-quarter financial forecasts.
• Springworks Therapeutics Inc.'s tumor treatment Ogsiveo received approval from U.S. regulators.
• Argenx SE shares fell following a discouraging update on a potential treatment for low blood platelet levels.
• PG&E Corp. reinstated its cash dividend for the first time since 2017.

3 Articles

Washington Post Associated Press Quartz